Inhibikase Therapeutics Inc (IKT)

Inhibikase Therapeutics Inc (IKT) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	100.00% -	0.000001	0.0796	0.1164	0.0645
Selling, General, and Administrative	2.0311	-	-	-	-
Costs And Expenses	8.60% 4.7824	4.4036	4.8484	6.3188	4.7795
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	8.60% -4.7824	-4.4036	-4.7689	-6.2024	-4.7149
Net Interest Income/Expense	41.17% 0.1327	0.2256	0.1737	0.4244	0.2372
Interest Income/Expense After Provision For Losses	41.17% 0.1327	0.2256	0.1737	0.4244	0.2372
Income/Loss From Continuing Operations Before Tax	8.60% -4.7824	-4.4036	-4.7689	-5.778	-4.4778
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	11.29% -4.6496	-4.1779	-4.5952	-5.778	-4.4778
Net Income/Loss	11.29% -4.6496	-4.1779	-4.5952	-5.778	-4.4778
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,226% 6.3407	0.2726	5.3423	5.2261	27.51
Diluted Average Shares	2,226% 6.3407	0.2726	5.3423	5.2261	27.51
Basic Earnings Per Share	14.06% -0.73	-0.64	-0.86	-1.11	-0.16
Diluted Earnings Per Share	14.06% -0.73	-0.64	-0.86	-1.11	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-